Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 5.0S - 9 mm: medical device reports filed with FDA

1,939 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,939
device reports naming the brand
0% of all MAUDE reports · about 271 a year
303
reports, 12 months to August 2026
319 in the 12 months before
0.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,939 reports that name the brand "OsseoSpeed TX 5.0S - 9 mm" (implant endosseous root-form), received between May 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

303 reports arrived in the 12 months to August 2026, close to the 319 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (38.6%), loss of osseointegration (32%) and osseointegration problem (29.1%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03059Sep 2021: 16Oct 2021: 17Nov 2021: 19Dec 2021: 152022Jan 2022: 19Feb 2022: 20Mar 2022: 28Apr 2022: 23May 2022: 14Jun 2022: 17Jul 2022: 15Aug 2022: 39Sep 2022: 14Oct 2022: 25Nov 2022: 22Dec 2022: 182023Jan 2023: 16Feb 2023: 20Mar 2023: 18Apr 2023: 18May 2023: 13Jun 2023: 21Jul 2023: 34Aug 2023: 59Sep 2023: 25Oct 2023: 26Nov 2023: 14Dec 2023: 142024Jan 2024: 28Feb 2024: 25Mar 2024: 25Apr 2024: 43May 2024: 33Jun 2024: 41Jul 2024: 27Aug 2024: 38Sep 2024: 35Oct 2024: 22Nov 2024: 18Dec 2024: 192025Jan 2025: 32Feb 2025: 19Mar 2025: 45Apr 2025: 10May 2025: 17Jun 2025: 18Jul 2025: 46Aug 2025: 38Sep 2025: 31Oct 2025: 15Nov 2025: 17Dec 2025: 132026Jan 2026: 53Feb 2026: 16Mar 2026: 28Apr 2026: 36May 2026: 19Jun 2026: 22Jul 2026: 35Aug 2026: 18

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02454892019: 3620192021: 48920212022: 25420222023: 27820232024: 35420242025: 30120252026: 2272026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.9%1,938
Malfunction0.1%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,939
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate74838.6%62.8%
Loss of osseointegration62132%22.4%
Osseointegration problem56529.1%7.7%
Fracturea broken bone80.4%1.6%
Loosening of implant not related to bone-ingrowth30.2%0.1%
Malposition of device30.2%0.1%
Insufficient device problem information20.1%0.2%
Patient-device incompatibilitythe device did not suit the patient20.1%0%
Difficult to insertthe device was hard to insert10.1%0.4%
Inadequacy of device shape and/or size10.1%0%
Loose or intermittent connection10.1%0%
Positioning problem10.1%0.1%
Scratched material10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,93599.8%
Inflammationinflammation24112.4%
Pocket erosion1447.4%
Osteolysis1125.8%
Implant pain100.5%
Painpain, site not specified40.2%
Inadequate osseointegration30.2%
Abscessa collection of pus20.1%
Debris, bone shedding20.1%
Necrosisdeath of tissue20.1%
Numbnessnumbness20.1%
Sinus perforation20.1%
Erosion10.1%
Swelling/ edema10.1%
Taste disorder10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 5.0S - 9 mmProduct code DZEAll MAUDE reports
Reports1,9393,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury99.9%99.2%36.2%
Classified as malfunction0.1%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 5.0S - 9 mm reports

How many FDA reports name OsseoSpeed TX 5.0S - 9 mm?

1,939 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 303 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (38.6%), loss of osseointegration (32%), osseointegration problem (29.1%), fracture (0.4%) and loosening of implant not related to bone-ingrowth (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 5.0S - 9 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.